Preliminary Program


Sunday, September 11, 2016
18:30-20:00Welcome Reception
Monday, September 12, 2016
08:00-09:00Registration & Refreshments & Exhibition Visit

Mr. Yossi Bornstein
, CEO Shizim, Chairman Cann 10 Israel 
Prof. Yehuda Shoenfeld, Head Zbludowicz Center for Autoimmune Diseases, Chaim Sheba Medical Center at Tel-Hashomer, Affiliated to Tel-Aviv University, Israel

09:25-09:55The Cannabinoids: Looking Back and Ahead
Prof. Raphael Mechoulam,
Institute for Drug Research, The Hebrew University of Jerusalem, Israel
09:55-10:15Pharmacokinetics, Application Forms and Quality of Cannabinoids - A Real Challenge
Prof. Rudolf Brenneisen, Head of Department of Clinical Research (DCR), University of Bern, Switzerland
10:15-10:30Coffee Break & Exhibition Visit  
 Science and Medical Track
Technology and Commercial Track Agriculture and Industry Track 

The Latest in Cannabis Research
Co - Chairs: Prof. Roger G. Pertwee, Scotland, UK & 
Prof. Zvi Bentwich, Israel

Multidisciplinary Technologies for Medical Cannabis Use
Co-Chairs: Prof. Aharon (Ari) Eyal, Israel & Dr. Avraham (Avi) Arbel, Israel  

 Recent Trends in Cannabis Cultivation
Co-Chairs: Dr. Oded Sagee, Israel & Dr. Noam Chehanovsky, Israel  



History and Future of Cannabis Clinical Research
Prof. Zvi Bentwich, Center of Tropical Diseases Center and AIDS, Ben Gurion University, and Chief Scientist Tikun Olam Ltd., Israel

Advanced Climate Control Systems for Year-Round Cannabis Greenhouses
Dr. Avraham (Avi) Arbel, Head, Department of Growing Production and Environmental Engineering Institute of Agricultural Engineering Agricultural Research Organization - The Volcani Center MOAG, Israel
The Use of Plant Growth Regulators in Cannabis Cultivation
Dr. Oded Sagee, Founder of Israel Plant Sciences ltd, CEO BreedIT ltd., CEO PlantExt ltd., Israel

Pharmacological Actions and Potential Novel Therapeutic Uses of Plant Cannabinoids: Great Expectations
Prof. Roger G. Pertwee
, MA, DPhil, DSc, HonFBPhS Institute of Medical Sciences University of Aberdeen, Scotland, UK

From Plant to Product: Design of a Robust and Consistent Cannabis Medication for Pain Using a Unique Formulation Technology to Capture the Complete Cannabinoid Complex
Dr. Shmuel Cohen, Lead Scientist Izun Pharmaceuticals Ltd, Israel/USA
Genetic Tools for Development of Medical Cannabis Strains
Dr. Noam Chehanovsky, Cannabis Geneticist and Breeder, Seed Specialist, CanOmix, Israel
From Anecdotal Knowledge to Evidence Based - The Future of Cannabis Research

Dr. David (Dedi) Meiri
, Assistant Professor, Heads the "Laboratory of Cancer Biology and Cannabinoid Research", Technion, Israel Institute of Technology, Israel                    

Biosynthesis of Cannabinoids - Commercial Process for Biosynthetic Production of authentic THCA, CBDA and CBCA Cannabinoids
Prof. Richard Peet, Executive Vice President, Chief Intellectual Property Counsel, Teewinot Life Sciences Coporation, USA

11: 10-11:30 

What Can You Do with Cannabis? Lessons from Model Plants
Prof. Asaph Aharoni, Scientist at the Department of Plant and Environmental Sciences, Faculty of Biochemistry, Weizmann Institute of Science, Israel

Peripheral vs Global Cannabinoid - 1 Receptor Blockade for the Treatment of the Metabolic Syndrome

Dr. Yossi (Joseph) Tam, Head, Obesity and Metabolism Laboratory, The Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Israel

Cannabis: Industrial Challenges, Business Opportunities and Science 
Prof. Aharon (Ari) Eyal, CSO, Bazelet Pharma, Israel

Cannabis Breeding: Present Trends and the Future
Mr. Gilad Livni
, Genetic Development and Consultant, Seach Ltd., Israel 

Pharmaceutical Challenges in the Delivery of THC and CBD

Prof. Abraham (Avi) J. Domb, Professor for Medicinal Chemistry and Biopolymers at the Faculty of Medicine of the Hebrew University, Jerusalem Azrieli - Jerusalem College of Engineering and Prof. Amnon HoffmanChairman, Division of Clinical Pharmacy Head, Pharm. D. Program, The Hebrew University of Jerusalem, Israel

The Latest Developments and Technologies in Cannabis Extraction, Cannabinoids Separation and Encapsulation
Mr. Emanuel Stanciu
, Sales and Application Manager, Organic Chemistry Department, Dr Golik, Israel

Elicitation Treatments for Regulation of Cannabinoids Production in Cannabis
Dr. Nirit Bernstein, Plant Physiology and Nutrition Institute of Soil Water and Environmental Sciences, Volcani Center, Israel 

Panel Discussion:

Moderated by: Prof. Zvi Bentwich
Subjects of Discussion:
1. Will the Future of Medical Cannabis Research be Based on: Synthetic Material or Cannabis Extract?
2. What are Today's Priorities in Medical Cannabis Areas of Research?

The Personal Cannabis: The Next Strain of Cannabis Based Products

Mr. Nadav Eyal, Co-Founder & CEO of Eybna Technologies, Israel

Cannabis Paving the Way for Disruptive Technologies in the U.S. Agriculture Technology Industry

Mr. Eli Duffy, Co-Founder, CEO of Grownetics, USA
12:40-13:30Free Oral Communication 1
Recent Research of Cannabinoids and Impact on Cannabis Use
Chair: Dr. Ilya Reznik, Israel
Free Oral Communication 2
Medical Indications and Clinical Trials of Medical Cannabis
Chair: Prof. Irit Akirav, Israel
Free Oral Communication 3
Aspects in Health Care Policy and Commercialization
Chair: Dr. Keren-or Amar, Israel 

Dr. István Ujváry, Hungary
The Cannabidiol Enigma: are The Metabolites of CBD Pharmacologically Active?

Prof. Irit Akirav, Israel
Targeting the Endocannabinoid System for Stress-Related Disorders
Dr. Jonathan Grunfeld, Israel
Medical Use of Cannabis: A Conflict of Paradigms, Current Processes and Decisions to be Made
 Dr. Gil Lewitus, Israel 
The Cannabinoids Diversity in the Various Cannabis Strains and Their Impact on Medical Use
Ms. Leah Bisiani, Australia
The Potential Scope of Medicinal Cannabis as an Alternative to Chronic Pain Management Regimes for Older Australians Living Within the Aged Care Sector
Dr. Ilan Nachim, Canada
Cannabinoids: A Canadian Experience


Dr. Ronen Shemesh, Israel  
Cannabinoid System as Targets for Fertility Enhancement

Dr. Lubov Blumkin, Israel
Medical Cannabis in Children with Complex Motor Disorders. Preliminary Results

Dr. Joe Wyse, Israel
Patent Data Analysis: A Predictive Tool for Medical Cannabis Investors and Innovators

Ms. Daphna katz, Israel
Cannabis and the BBB - A Possible New Approach for Neurologic Autoimmune Diseases?

Dr. Daphna Heffetz, Israel
Innovative Cannabinoid Oral Pills: Clinical Study Results and Future Plans

Mr. Mark Fishman, Israel
Indoor Cultivation for Medical Cannabis is a Must and Now it`s Economically Feasible
 Ms. Lihi Bar-Lev Schleider, Israel
Short and Long term Clinical Outcomes in Large Unselected Cohort of Patients Treated with Medical Cannabis

Dr. Debra Kimless, USA
Palliative Care to Remission: Use of Low Dose Cannabis Oil in an 8 Year Old, all Patient with Metastasis

Dr. Stanislav Grosu, Moldova
Cannabinoid Research Interest in Republic of Moldova


Mr. Joshua Aviram, Israel
A Multi-Center Registry of Medical Cannabis (MC) for Chronic Pain: Initial Results

Dr. Michele Pfannenstiel, USA
The Importance of Best Practices and Certification in the Global Cannabis Industry
13:30-14:30Lunch Break & Exhibition Visit

Live from NY
Mr. Leslie Bocskor
, Founder and President, Electrum Partners, USA
How to become a Part of the Growing U.S Cannabis Market?
What Israeli Startups/Companies need to do and know in order to attract investors

Workshop: Cannabis Quality Assessment
Sébastien Béguerie,
Founder & CEO Alpha-CAT, Coordinator, InternationalMedical Cannabis Patient Coalition
(IMCPC), France


Panel Discussion: Who's afraid of Medical Cannabis?
Moderator: Yuval (Tuby) Zolotov, Israel

Survey: Assessment of Israeli Physicians Knowledge, Experience and Attitudes towards Medical Cannabis, Yuval (Tuby) ZolotovM.H.A PhD Candidate, School of Public Health, University of Haifa, Israel 
Panel Participants:
Amir Ohana Mk, (Likud), Member, Lobby for Medical CannabisDr. Bareket Schiff-Keren, Pain Management Specialist, IsraelDr. Bat Sheva Porat KatzTel-Aviv District Health Bureau, Ministry of Health,Israel; Prof.  Elyad DavidsonDirector Pain Relief Unit, Dept. of Anesthesia & CCM, Hadassah University Hospital, Israel; Mr. David Pappo, Chairman of the Pharmaceutical Association of Israel Central Council, Israel; Dana Bar-on, Coordinator, Lobby for Medical Cannabis 

15:45-16:00Coffee Break & Exhibition Visit  

Science and Medical Track

Technology and Commercial Track 

Cannabis and Oncology - Is Cannabis on the Path Towards Curing Cancer
Chair: Prof. Reuven Or, Israel &
Prof. Gil Bar-Sela, Israel

Law and Order - Cannabis Market in Dynamic Environment
Chair: Yoav Etzyon, Israel


The Use of Cannabis-Based Medicines in Hematopoietic Stem Cell Transplantation: Lessons from the Clinic and the Laboratory
Prof. Reuven Or,
Director of The Department of Bone Marrow Transplantation Cancer Immunotherapy & Immunobiology Research Center Hadassah University Hospital, Israel

Medical Cannabis Production in Israel in the New Governmental Policy: Economic Impacts
Dr. Dan Dvoskin,
Financial – Agricultural senior Advisor, Israel


Cannabis and Synthetic Cannabinoids for Palliative Indication in Cancer Patients

Prof. Gil Bar-Sela, Deputy Director of the Division of Oncology at Rambam Health Care Campus, Head of the Palliative and Supportive Oncology Unit, Israel

Developments in the Regulatory Environment of Cannabis in Israel- Opportunities and Prospects
Mr. Yoav Etzyon
, Advospects Partner, APM, Israel

In vitro and in vivo Efficacy of Non-Psychoactive Cannabidiol in Neuroblastoma
Prof. Amos Toren,
Head of Pediatric Hemato-Oncology at the Sheba Medical Center - Tel Hashomer, Israel
Pharma Cannabis Marketing - Competing with the Street Market 

Ms. Rita Alter, MSc. Medical Cannabis Marketing Consultant, Israel
Tuesday, September 13, 2016
08:00-09:00Registration & Refreshments & Exhibition Visit  
 Science and Medical Track
Technology and Commercial Track 
09:00-10:20Cannabis Treatments Benefits vs Risks
Chair: Prof. Yehuda Shoenfeld
Prof. Fred Meir Konikoff, Israel 
Is Medical Cannabis a Passing Trend or Sustainable Business? 
 Co-Chairs: David Spitz, USA & ADV. Ken Shaked, Israel













Cannabis in Inflammatory Bowel Diseases - from Anecdotal Use to Medicalization?
Prof. Fred Meir Konikoff,
 Head of the Department of Gastroenterology and Hepatology, Meir Medical Center, Israel 
Medical Cannabis Business: Current Status, Trends & The Future
ADV. Ken Shaked,
Founder of Shaked & Co, Law Offices, Israel

Anti-Inflammation Properties of Cannabidiol vs. Cannabis Extract
Prof. Ruth Gallily
Department of Immunology, Hebrew University, Jerusalem, Israel

Marijuana based Products - Product Strategies
Mr. David Spitz,
Hi-End Medical Cannabis Grower in Colorado, USA 

Is there Room for Cannabis Treatment in Rheumatic Conditions? 
Prof. Howard Amital, 
Department of Internal Medicine B and Research Center for Autoimmune Diseases, Sheba Medical Center - Tel Hashomer, Israel
Global Economy Trend in Cannabis
Mr. Saul Kaye, Pharmacist & Entrepreneur, Founder and CEO, iCAN: Israel-Cannabis, Israel
Cannabis in Autoimmune Diseases
Prof. Yehuda Shoenfeld
Head of The Zabludowicz Center For Autoimmune Diseases, Sheba Medical Center - Tel Hashomer, Israel
Medical Cannabis in Spain and Germany – Operating within a Restricted, Complex Legal Framework
Dr. Henrik Sprengel, CEO, Kalapa-Project, Spain


Pain - relief, Self - Medication and Addiction - Promises and Perils of Medical Marijuana
Chairs: Dr. Shaul Lev-Ran, Israel & Dr. Leora Schachter, Israel

Opening Lecture:
Psychiatric Outcomes of Cannabis Use: Why don't we have a Simple Answer to a "Simple" Question
Dr. Shaul Lev-Ran,
Director, Addiction Medicine Dual Disorders Clinic, Lev Hasharon Medical Center, Israel

Panel Discussion:
Prof. Pinhas N DannonPsychiatry, Psychosomatic Medicine, Addiction Medicine, Faculty of Medicine Tel Aviv University, Israel

Dr. Leora Schachter, Head of Main Management, Maccabi Healthcare Services, Israel

Panel Discussion: Investments in Medical Cannabis: an Adventure or the Real Thing?

Moderator: ADV. Ayelet Torem, 
APM co. Partner at High Tech and Venture Capital Department, Israel
Participant: Mr. Doron Ben Ami, VP Strategy, Therapix Biosciences, Israel 
Mr. Elie Gordis, Co-founder, Alta-Fund, USA, Hadar Sutovsky, VP Technologies & New Ventures at Earthbound & General Partner at Aquagro Fund LP, Dr. Eyal Ballan, CTO at Cannabis Pharmaceuticals Inc., Israel and Dr. Ascher Shmulewitz 


11:30-12:00Coffee Break & Exhibition Visit  

Plenary Session: The Impact of Global Policies on Medical Cannabis Research
Moderator: Mr. Zach Klein,
Cannabis Researcher and Filmmaker, Israel 

The Politics of Marijuana: Myths & Misinformation - The Colorado Experience
Mr. Mike Dunafon
Mayor of Glendale, Colorado, USA

Israeli Medical Cannabis Policy – How to Break Free from the Stigma?
Tamar Zandberg MK
(Meretz), Chair Knesset Committee on Drug and Alcohol Abuse, Israel

Israel :The challenge of Innovation and Meaningful Message in a Centralized, Fixed and Regulatory Environment 
Mr. Moshe Feiglin,
Chairman of the Zehut Party, Former Deputy Speaker of the Knesset, Israel 

13:00-14:00Lunch Break & Exhibition Visit  
 Science and Medical Track Technology and Commercial Track
 Personalized Cannabis Treatment: For Special Populations
Co Chairs: Prof. Lumir Hanus &
Prof. Uri Kramer,Israel
Challenges in the Cannabis Market: Intellectual Property, Break Boundaries to New Markets
Chair: Mr. Meir Fenster, Israel
Cannabis Treatment - Not as Simple as it Looks
Prof. Lumir Hanus,
School of Pharmacy, The Hebrew University, Israel

Understanding how to use Intellectual Property
Mr. Maier Fenster, Lead Patent Attorney, Head of Medical Devices Department, Ehrlich & Fenster, Israel

Cannabis for Treatment of Children with Severe Epilepsy - Promising Results
Prof. Uri Kramer
Director of Pediatric Epilepsy Service, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

The Challenges of Patent Protecting Medicinal Uses of Cannabis - A Substance Known for Thousands of Years
Ms. Tamar Gallily
Patent Attorney, Yissum Research Development Company of the Hebrew University in Jerusalem, Israel

Cannabis in Care for Medically Complex Older Persons
Prof. Jacob Gindin,
DHead of Geriatric services at Assuta Medical Center, Israel

A Unique Nasal Delivery Approach for Effective and User Friendly Cannabis Based Therapeutics
Dr. Iris Shichor,
PhD., CEO, SipNose Ltd. Israel

Experience with Medical Cannabis in Complex PTSD
Dr. Alan J. Flashman
Pediatrician, Psychiatrist, Child Psychiatrist, Family Therapist Former Adjunct Faculty, Paul Baerwald School of Social Work, The Hebrew University of Jerusalem, Israel
Israeli Pharmaceutical Industry Enters the US Cannabis Market
Dr. Dadi Segal,
Founder Panaxia Ltd., ISrael
Using Medical Cannabis to Treat Inflammatory Bowel Diseases: Specific Lines, Personalized Treatment
Dr. Hinanit Koltai
, PhD, Institute of Plant Science ARO, Volcani Center, HaMaccabim Road, Rishon LeTsiyon, Israel

15:30-16:30Interactive Panel: Everyday & Advanced Techniques for Effective Use of Cannabis for Medical Purposes
Chair: Dr. Ilya Reznik, psychiatrist, Board of Directors, International Association for Cannabinoid Medicines, (IACM)
Participants are Experienced Instructors of Cannabis Use for Medical Purposes: Ms. 
Inbal Sikorin, Chief Nurse at Tikun Olam and Hadarim Nursing Home, Kibutz Naan, Mr. Nisan Eizenboim, Patient treated by Cannabis and Instructor, Ms. Adina Wallerstein, Medical Strains Consultancy & Patient Assistance, Seach and Ms. Orit Izraelov, Patients Instructor, Bazelet